An enzymatic platform for the synthesis of isoprenoid precursors.
The isoprenoid family of compounds is estimated to contain ∼ 65,000 unique structures including medicines, fragrances, and biofuels. Due to their structural complexity, many isoprenoids can only be obtained by extraction from natural sources, an inherently risky and costly process. Consequently, the...
Main Authors: | Sofia B Rodriguez, Thomas S Leyh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4143292?pdf=render |
Similar Items
-
Engineering Pseudomonas putida for isoprenoid production by manipulating endogenous and shunt pathways supplying precursors
by: Sofía Hernandez-Arranz, et al.
Published: (2019-09-01) -
Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli
by: Wang, Y., et al.
Published: (2013) -
Two-step pathway for isoprenoid synthesis
by: Chatzivasileiou, Alkiviadis Orfefs, et al.
Published: (2021) -
Synthesis, function, and regulation of sterol and nonsterol isoprenoids
by: Rebecca Faulkner, et al.
Published: (2022-10-01) -
Growth-uncoupled isoprenoid synthesis in Rhodobacter sphaeroides
by: Enrico Orsi, et al.
Published: (2020-07-01)